Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Medicine|July 26, 2024
Treatment with ensitrelvir for COVID-19 in hospitalized patients of very advanced age: Case seriesTakafumi Tomita, Shogo Miyazawa, Takuhiro SonoyamaClinical Drug Investigation|January 20, 2025
Safety, Tolerability, and Pharmacokinetics of a Novel Anti-obesity Agent, S-309309, in Healthy Adults with or Without ObesityToru Ishibashi, Hideki Tanioka, Tatsuya Ikehara, et al.Clinical Drug Investigation|March 31, 2026
Effects of Ensitrelvir on the Pharmacokinetics of Combined Oral Contraceptives (Ethinyl Estradiol/Drospirenone) in Healthy Adult Women: A Phase 1 Fixed-Sequence, Multiple-Dose, Drug-Drug Interaction StudyRyosuke Shimizu, Risa Yokokawa Shibata, Ryuji Kubota, et al.Clinical Drug Investigation|October 5, 2023
A Phase 1 Study of Ensitrelvir Fumaric Acid Tablets Evaluating the Safety, Pharmacokinetics and Food Effect in Healthy Adult PopulationsRyosuke Shimizu, Takuhiro Sonoyama, Takahiro Fukuhara, et al.Antimicrobial Agents and Chemotherapy|September 12, 2022
Safety, Tolerability, and Pharmacokinetics of the Novel Antiviral Agent Ensitrelvir Fumaric Acid, a SARS-CoV-2 3CL Protease Inhibitor, in Healthy AdultsRyosuke Shimizu, Takuhiro Sonoyama, Takahiro Fukuhara, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 28, 2021
Open-label study of the safety, pharmacokinetics, and effectiveness of a 2 mg/kg dose of baloxavir marboxil 2% granules in children <20 kg with influenzaTakuhiro Sonoyama, Hiroki Sakaguchi, Hiroki Koshimichi, et al.Infectious Diseases and Therapy|April 19, 2025
Ensitrelvir in Hospitalized Patients with SARS-CoV-2 During the Omicron Epidemic: A Single-Center Observational StudyMasaya Yamato, Masahiro Kinoshita, Yuki Yoshida, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 17, 2024
Ensitrelvir in patients with SARS-CoV-2: A retrospective chart reviewMasaya Yamato, Masahiro Kinoshita, Shogo Miyazawa, et al.Clinical Drug Investigation|May 12, 2023
Evaluation of the Drug-Drug Interaction Potential of Ensitrelvir Fumaric Acid with Cytochrome P450 3A Substrates in Healthy Japanese AdultsRyosuke Shimizu, Takuhiro Sonoyama, Takahiro Fukuhara, et al.Current Medical Research and Opinion|December 14, 2021
Relationship between baseline clinical characteristics and efficacy of lusutrombopag in thrombocytopenic patients with chronic liver disease: <i>post hoc</i> analysis of two placebo-controlled phase 3 trialsKatsuaki Tanaka, Takamichi Baba, Manami Yoshida, et al.Pageof 6